The spine bone stimulators market was valued at $562 million in 2015, and is projected to reach $724 million by 2022, growing at a CAGR of 3.6% from 2016 to 2022. The market is driven by the increase in geriatric population, and rise in incidence of osteoporosis and arthritis. However, advent of bone growth-stimulating drugs, fixation instrumentation during fusion and non-union fractures, and high initial cost of these devices are expected to impede this market growth.
The report segments the spine bone stimulators market based on product type, surgery, and region. On the basis of product type, the market is bifurcated into non-invasive and invasive stimulators. By surgery type, it is divided into open spine surgery and minimally invasive spine surgery. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market has witnessed launch of various spine bone stimulators that are used for spinal fusion. For instance, the product range of Orthofix International NV for bone stimulation has stimulated the market growth. Next-generation bone growth stimulation products-Physio-Stim(R) and Spinal-Stim(R) have empowered the company to increase its market share in the total spine stimulation market.
KEY BENEFITS FOR STAKEHOLDERS
This report offers an extensive analysis of the current trends and emerging estimations through 2014–2022 of the global spine bone stimulators market, which assist to identify the prevailing opportunities.
Comprehensive analysis of all geographical regions and factors that drive and restrict the market growth is provided.
Quantitative analysis of the market from 2014 to 2022 is provided to showcase the financial scenario of the market.
The market conditions are comprehensively analyzed region- and country-wise.
KEY MARKET SEGMENTS
Non-Invasive Spine Bone Stimulators
Pulsed Electromagnetic Field Device
Capacitive Coupling(CC) and Combined (Electro) Magnetic Field (CMF) Devices
Invasive Spine Bone Stimulators
Open Spine Surgery
Minimally Invasive Spine Surgery
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
1.1. Key Benefits
1.2. Key Market Segments
1.3. Key Players
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2 Executive Summary
2.1. Key Findings Of The Study
2.2. CXO Perspective
Chapter 3 Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Winning Strategies
188.8.131.52. Competitive Intelligence And Strategies Of Companies
3.2.2. Top Investment Pockets
3.3. Market Share Analysis, 2015
3.4. Market Dynamics
184.108.40.206. Growing Elderly Population
220.127.116.11. Increasing Prevalence Of Spinal Disorders
18.104.22.168. Advancements In Spine Surgery
22.214.171.124. Availability Of Substitutes
126.96.36.199. High Initial Cost Of The Device
188.8.131.52. Emerging Markets To Drive The Demand For Spine Bone Stimulators
184.108.40.206. Motion Preservation Surgery
3.4.4. Impact Analysis
3.5. Porters Five Forces Analysis
3.5.1. Bargaining Power Of Buyers
3.5.2. Bargaining Power Of Suppliers
3.5.3. Threat Of Substitutes
3.5.4. Threat Of New Entrants
3.5.5. Competitive Rivalry
3.6. Government Regulations
Chapter 4 Global Spine Bone Stimulators Market, By Product
4.1.1. Key Market Trends
4.1.2. Growth Factors And Opportunities
4.1.3. Market Size And Forecast
4.1.4. Global Spinal Bone Stimulator Implantations, By Type
4.1.5. Non-Invasive Spine Bone Stimulators
220.127.116.11. Market Size And Forecast
18.104.22.168.1. Pulsed Electromagnetic Field Device
22.214.171.124.1.1. Market Size And Forecast
126.96.36.199.2. Capacitive Coupling And Combined Magnetic Field Device
188.8.131.52.2.1. Market Size And Forecast
4.1.6. Invasive Spine Bone Stimulators
184.108.40.206. Market Size And Forecast
Chapter 5 Global Spine Bone Stimulators Market, By Surgery
5.1.1. Market Size And Forecast
5.2. Open Spine Surgery
5.2.1. Market Size And Forecast
5.3. Minimally Invasive Spine Surgery
5.3.1. Market Size And Forecast
Chapter 6 Global Spine Bone Stimulators Market, By Region
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends
6.2.2. Growth Factors And Opportunities
6.2.3. Market Size And Forecast
6.2.4. U.S. Market Size And Forecast
6.2.5. Canada Market Size And Forecast
6.2.6. Mexico Market Size And Forecast
6.3.1. Key Market Trends
6.3.2. Growth Factors And Opportunities
6.3.3. Market Size And Forecast
6.3.4. France Market Size And Forecast
6.3.5. Germany Market Size And Forecast
6.3.6. Uk Market Size And Forecast
6.3.7. Spain Market Size And Forecast
6.3.8. Italy Market Size And Forecast
6.3.9. Rest Of Europe Market Size And Forecast
6.4.1. Key Market Trends
6.4.2. Growth Factors And Opportunities
6.4.3. Market Size And Forecast
6.4.4. India Market Size And Forecast
6.4.5. China Market Size And Forecast
6.4.6. Japan Market Size And Forecast
6.4.7. South Korea Market Size And Forecast
6.4.8. Australia Market Size And Forecast
6.4.9. Rest Of Asia-Pacific Market Size And Forecast
6.5.1. Key Market Trends
6.5.2. Growth Factors And Opportunities
6.5.3. Market Size And Forecast
6.5.4. Brazil Market Size And Forecast
6.5.5. Saudi Arabia Market Size And Forecast
6.5.6. South Africa Market Size And Forecast
6.5.7. Rest Of Lamea Market Size And Forecast
Chapter 7 Company Profiles
7.1. Aetna, Inc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Product Categories
7.1.4. Business Performance
7.1.5. Key Strategic Moves And Developments
7.2. Bioventus Llc
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Business Performance
7.3. Djo Global, Inc.
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Business Performance
7.3.5. Key Strategic Moves And Developments
7.3.6. Key Strategic Share
7.4. Elizur Corporation
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Business Performance
7.4.5. Key Strategic Moves And Developments
7.5. Igea S.P.A.
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Product Categories
7.5.4. Business Performance
7.5.5. Key Strategic Moves And Developments
7.5.6. Key Strategy Share
7.6. Medtronic Plc
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Business Performance
7.6.5. Key Strategic Moves And Developments
7.6.6. Key Strategy Share
7.7. Orchid Medical, Inc.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Business Performance
7.7.5. Key Strategic Moves And Developments
7.7.6. Key Strategy Share
7.8. Orthofix International N.V.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Business Performance
7.8.5. Key Strategic Moves And Developments, 2014-2016
7.8.6. Key Strategy Share, 2014-2016 (%)
7.9. Ossatec Benelux B.V.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Business Performance
7.9.5. Key Strategic Moves And Developments, 2014-2016
7.10. Smith & Nephew Plc
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Product Categories
7.10.4. Business Performance
7.10.5. Key Strategic Moves And Developments
7.10.6. Key Strategy Share
Spine bone stimulators and spinal instrumentation (plates, rods, and screws) and bone grafts are used during a spinal fusion surgery to enhance the bones healing process. These stimulators send low-level electrical signals to the fusion site, in turn activating the body's natural bone healing process, which gets impaired in at-risk patients, preventing delayed unions or non-union of the spine fractures.
Increase in geriatric population and rise in incidence of osteoporosis and arthritis boost the market growth. However, advent of bone growth-stimulating drugs, fixation instrumentation during fusion and non-union fractures, and high initial cost of these devices are expected to impede the market growth. Non-invasive spine bone stimulators were the highest revenue-generating segment, accounting for more than two-thirds of the spine bone stimulators market.
Key findings of Spine Bone Stimulators Market:
Non-invasive spine bone stimulators segment is expected to grow at a CAGR of 3.6% during the forecast period.
Pulsed electromagnetic field device occupied more than three-fifths of the global non-invasive spine bone stimulators market in 2015.
North America dominated and accounted for nearly two-thirds of the global market in 2015.
France and Germany collectively accounted for almost one-third of the European spine bone stimulators market in 2015.
Japan was the major shareholder in Asia-Pacific spine bone stimulators market in 2015, accounting for almost one-third share.
North America accounted for the major share of revenue in 2015, and is expected to maintain its dominance throughout the forecast period. However, Asia-Pacific is projected to be the fastest growing region, registering a CAGR of 4.5%. Improvement in healthcare infrastructure and increase in expenditure in emerging markets (such as India and China) to overcome the unmet medical needs in these countries have supplemented the market growth.
The key players operating in the spine bone stimulators market focus on expanding their business operations in emerging countries with new product launches as a preferred strategy. The major companies profiled in the report include Aetna, Inc., Bioventus LLC, DJO Global, Inc., elizur Corporation, IGEA S.p.A., Medtronic plc, Orchid Medical, Inc., Orthofix International N.V., Ossatec Benelux B.V., Smith & Nephew plc, Verve Consulting Inc., and Zimmer Biomet Holdings, Inc.